The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma

Published:2020-10-16 Issue:21 Volume:19 Page:2918-2926
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Li Zhenqing¹²,Xue Qun³,Xu Jianxun¹²,Zhang Pengfei¹²,Ding Bo¹²

Affiliation:

1. Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, JiangsuProvince, China

2. Medical College of Nantong University, Nantong, Jiangsu, China

3. Cardiovascular Surgery Department, Affiliated Hospital of Nantong University, Nantong, JiangsuProvince China

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2020.1829801

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer treatment and survivorship statistics, 2014

3. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC

4. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

5. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular impact of mutations in RNA splicing factors in cancer;Molecular Cell;2024-08

2. RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer;Clinical Lung Cancer;2024-07

3. Genetic alterations predict poor efficacy, outcomes and resistance to second-line osimertinib treatment in non-small cell lung cancer;American Journal of Cancer Research;2024

4. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD);Biomedicines;2023-06-29

5. RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC;Cancer Cell International;2022-11-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3